Current Alzheimer Research
Volume 16, 14 Issues, 2019
ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)
This journal supports open access
ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)
This journal supports open access
Ranking and Category
-
66th of 199 in
Clinical Neurology
-
115th of 267 in
Neurosciences
Contents
Current Alzheimer Research, Volume 6 - Number 5
Editorial [Hot topic: A Multi-Targeted Approach for a Complex Multifaceted Disease (Guest Editors: D.W. Shineman and H.M. Fillit)]
, 6(5): 407 - 408D. W. Shineman and H. M. Fillit
DOI: 10.2174/156720509789207958
Modulation and Detection of Tau Aggregation with Small-Molecule Ligands
, 6(5): 409 - 414Edward Chang, Nicolette S. Honson, Bhaswati Bandyopadhyay, Kristen E. Funk, Jordan R. Jensen, Sohee Kim, Swati Naphade and Jeff Kuret
DOI: 10.2174/156720509789207976
Understanding the Basis for the Association of apoE4 with Alzheimers Disease: Opening the Door for Therapeutic Approaches
, 6(5): 415 - 418Ning Zhong and Karl H. Weisgraber
DOI: 10.2174/156720509789207921
A Neurotrophic Rationale for the Therapy of Neurodegenerative Disorders
, 6(5): 419 - 423H. Uri Saragovi, Edith Hamel and Adriana Di Polo
DOI: 10.2174/156720509789207912
Suppression of Glial HO-1 Activitiy as a Potential Neurotherapeutic Intervention in AD
, 6(5): 424 - 430Hyman M. Schipper, Ajay Gupta and Walter A. Szarek
DOI: 10.2174/156720509789207985
A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimers Disease
, 6(5): 431 - 437Sergey Kalinin, Jill C. Richardson and Douglas L. Feinstein
DOI: 10.2174/156720509789207949
Tau-Focused Immunotherapy for Alzheimers Disease and Related Tauopathies
, 6(5): 446 - 450Einar M. Sigurdsson
DOI: 10.2174/156720509789207930
O-GlcNAc Modification and the Tauopathies: Insights from Chemical Biology
, 6(5): 451 - 454Scott A. Yuzwa and David J. Vocadlo
DOI: 10.2174/156720509789207967
Addressing Alzheimers Disease Tangles: From NAP to AL-108
, 6(5): 455 - 460Illana Gozes, Alistair Stewart, Bruce Morimoto, Anthony Fox, Karole Sutherland and Donald Schmechel
DOI: 10.2174/156720509789207895
  |
Editor-in-Chief
Prof. Debomoy K. Lahiri
(15455 citations)
Neuroscience Research Center
Indianapolis, IN 46202
USA
Biography
View Full Editorial Board
(15455 citations)
Neuroscience Research Center
Indianapolis, IN 46202
USA
Biography
Biography of Debomoy K. Lahiri
Dr. Debomoy Lahiri is Professor at Indiana University School of Medicine, USA. His major research focus is to understand the mechanism of aging, origin and biogenesis of the amyloid plaque, and to discover drug targets for Alzheimer's disease (AD) and other brain disorders. Dr. Lahiri’s group has shown the novel role of specific microRNA species in regulation of genes implicated in AD as well as the role of gene and environment interaction in late-life disorders. Also, his team has made significant contributions to understanding the biochemical pathway for neurodevelopment disorders, such as autism and fragile X syndrome. Dr. Lahiri is the Editor-In-Chief of the international journal, ‘Current Alzheimer Research' (Bentham). He authored books, such as ‘Protective Strategies for Neurodegenerative Diseases' published by the New York Academy of Sciences. Dr. Lahiri was awarded grants as a Principal Investigator from the National Institute on Aging, NIH, and Alzheimer’s Association, USA. His other honors include the ‘Zenith Award’ and listing in Marquis' ‘Who's Who in the World'.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Alzheimer Research was introduced in 2004 with the assistance of Dr. Debomoy K. Lahiri, who is the current Editor-in-Chief serving since 2004.
Scopus CiteScore Metrics: 1.43
New eBook
 |
Frontiers in Clinical Drug Research – Alzheimer DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net